超声内镜引导下的胃肠造口术治疗胃轻瘫难治性胃经口内镜幽门切开术:一个有前途的新治疗选择

iGIE Pub Date : 2025-03-01 DOI:10.1016/j.igie.2025.01.011
Jean-Michel Gonzalez MD, PhD, Juliette Phelip MD, Mohamed Gasmi MD, Véronique Vitton MD, PhD, Marc Barthet MD, PhD
{"title":"超声内镜引导下的胃肠造口术治疗胃轻瘫难治性胃经口内镜幽门切开术:一个有前途的新治疗选择","authors":"Jean-Michel Gonzalez MD, PhD,&nbsp;Juliette Phelip MD,&nbsp;Mohamed Gasmi MD,&nbsp;Véronique Vitton MD, PhD,&nbsp;Marc Barthet MD, PhD","doi":"10.1016/j.igie.2025.01.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and Aims</h3><div>Gastric peroral endoscopic myotomy (G-POEM) reaches an efficacy rate around 65% for gastroparesis. Endoscopic ultrasound (EUS)–guided gastroenteroanastomosis (EUS-GEA) has demonstrated efficacy in gastric outlet obstruction. We evaluated it for refractory gastroparesis.</div></div><div><h3>Methods</h3><div>We undertook a single-center retrospective study enrolling patients with gastroparesis treated with G-POEM with failure or symptoms recurrence managed with EUS-GEA. The drain-assisted EUS-GEA technique with 20-mm lumen-apposing stent was applied. End points were clinical efficacy at 6 months, adverse events, and recurrence rate.</div></div><div><h3>Results</h3><div>Twelve patients were included, median age 46 years (interquartile range [IQR], 16-78 y). Patients had an abnormal gastric emptying or bezoar, and 50% never improved from baseline. Median follow-up was 11.5 months (IQR, 6-26 mo). Clinical efficacy rate was 75% at 6 months. The median preoperative Gastroparesis Cardinal Symptoms Index was 4.1 (IQR, 1.6-5) versus 1.6 (IQR, 0-2.6; <em>P</em> &lt; .05). No severe periprocedural adverse events occurred.</div></div><div><h3>Conclusions</h3><div>EUS-GEA demonstrated promising results in improving patients with gastroparesis refractory to G-POEM. Prospective evaluation is required to confirm these results.</div></div>","PeriodicalId":100652,"journal":{"name":"iGIE","volume":"4 1","pages":"Pages 16-20"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Endoscopic ultrasound–guided gastroenterostomy for managing gastroparesis refractory to gastric peroral endoscopic pylorotomy: a promising new therapeutic option\",\"authors\":\"Jean-Michel Gonzalez MD, PhD,&nbsp;Juliette Phelip MD,&nbsp;Mohamed Gasmi MD,&nbsp;Véronique Vitton MD, PhD,&nbsp;Marc Barthet MD, PhD\",\"doi\":\"10.1016/j.igie.2025.01.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background and Aims</h3><div>Gastric peroral endoscopic myotomy (G-POEM) reaches an efficacy rate around 65% for gastroparesis. Endoscopic ultrasound (EUS)–guided gastroenteroanastomosis (EUS-GEA) has demonstrated efficacy in gastric outlet obstruction. We evaluated it for refractory gastroparesis.</div></div><div><h3>Methods</h3><div>We undertook a single-center retrospective study enrolling patients with gastroparesis treated with G-POEM with failure or symptoms recurrence managed with EUS-GEA. The drain-assisted EUS-GEA technique with 20-mm lumen-apposing stent was applied. End points were clinical efficacy at 6 months, adverse events, and recurrence rate.</div></div><div><h3>Results</h3><div>Twelve patients were included, median age 46 years (interquartile range [IQR], 16-78 y). Patients had an abnormal gastric emptying or bezoar, and 50% never improved from baseline. Median follow-up was 11.5 months (IQR, 6-26 mo). Clinical efficacy rate was 75% at 6 months. The median preoperative Gastroparesis Cardinal Symptoms Index was 4.1 (IQR, 1.6-5) versus 1.6 (IQR, 0-2.6; <em>P</em> &lt; .05). No severe periprocedural adverse events occurred.</div></div><div><h3>Conclusions</h3><div>EUS-GEA demonstrated promising results in improving patients with gastroparesis refractory to G-POEM. Prospective evaluation is required to confirm these results.</div></div>\",\"PeriodicalId\":100652,\"journal\":{\"name\":\"iGIE\",\"volume\":\"4 1\",\"pages\":\"Pages 16-20\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"iGIE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2949708625000111\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"iGIE","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949708625000111","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景与目的经口胃镜下肌切开术(G-POEM)治疗胃轻瘫的有效率约为65%。超声内镜(EUS)引导下的胃肠吻合术(EUS- gea)治疗胃出口梗阻的疗效显著。我们对难治性胃轻瘫进行了评估。方法:我们进行了一项单中心回顾性研究,纳入了用G-POEM治疗胃轻瘫,用EUS-GEA治疗失败或症状复发的患者。采用引流辅助EUS-GEA技术配合20mm管腔旁置支架。终点为6个月的临床疗效、不良事件和复发率。结果纳入12例患者,中位年龄46岁(四分位间距[IQR], 16-78岁),患者有胃排空或牛黄异常,50%的患者从未从基线改善。中位随访时间为11.5个月(IQR, 6-26个月)。6个月临床有效率75%。术前胃轻瘫主要症状指数中位数为4.1 (IQR, 1.6-5)对1.6 (IQR, 0-2.6;P & lt;. 05)。未发生严重的围手术期不良事件。结论seus - gea对G-POEM难治性胃轻瘫患者的治疗效果良好。需要前瞻性评价来证实这些结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Endoscopic ultrasound–guided gastroenterostomy for managing gastroparesis refractory to gastric peroral endoscopic pylorotomy: a promising new therapeutic option

Background and Aims

Gastric peroral endoscopic myotomy (G-POEM) reaches an efficacy rate around 65% for gastroparesis. Endoscopic ultrasound (EUS)–guided gastroenteroanastomosis (EUS-GEA) has demonstrated efficacy in gastric outlet obstruction. We evaluated it for refractory gastroparesis.

Methods

We undertook a single-center retrospective study enrolling patients with gastroparesis treated with G-POEM with failure or symptoms recurrence managed with EUS-GEA. The drain-assisted EUS-GEA technique with 20-mm lumen-apposing stent was applied. End points were clinical efficacy at 6 months, adverse events, and recurrence rate.

Results

Twelve patients were included, median age 46 years (interquartile range [IQR], 16-78 y). Patients had an abnormal gastric emptying or bezoar, and 50% never improved from baseline. Median follow-up was 11.5 months (IQR, 6-26 mo). Clinical efficacy rate was 75% at 6 months. The median preoperative Gastroparesis Cardinal Symptoms Index was 4.1 (IQR, 1.6-5) versus 1.6 (IQR, 0-2.6; P < .05). No severe periprocedural adverse events occurred.

Conclusions

EUS-GEA demonstrated promising results in improving patients with gastroparesis refractory to G-POEM. Prospective evaluation is required to confirm these results.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信